February 2026

Obesity affects one in three adults in Australia and is increasingly encountered in everyday general practice. Structured, compassionate assessment can help identify obesity-associated complications
and inform appropriate behavioural, pharmacological and surgical management options.

Fracture risk in older people is driven by the triad of low bone strength, frailty and increased propensity to fall. For those at the highest risk of imminent fracture, the treatment paradigm has evolved to prioritise potent osteoanabolic agents, followed by antiresorptive therapy to consolidate skeletal gains.

Hypoparathyroidism is a multisystem disorder that causes hypocalcaemia and significant morbidity. Conventional calcium and calcitriol supplementation normalises serum calcium but does not address all clinical challenges. Palopegteriparatide, a long-acting parathyroid hormone analogue, may offer improved outcomes but is not yet PBS subsidised in Australia.